A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade

American Journal of Pathology

Volumn 169, Issue 5, 2006, Pages 1577-1589

  Okada, Hirokazu ^a   Inoue, Tsutomu ^a   Kikuta, Tomohiro ^a   Watanabe, Yusuke ^a   Kanno, Yoshihiko ^a   Ban, Shinichi ^a   Sugaya, Takeshi ^b   Horiuchi, Masatsugu ^c   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b RIKEN KOBE INSTITUTE   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEEDBACK SYSTEM; FIBROGENESIS; GLOMERULONEPHRITIS; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATION; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; TIME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; CHEMOKINE CCL2; ENZYME ACTIVATION; EPITHELIAL CELLS; EPITHELIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY TUBULES; MALE; MICE; NF-KAPPA B; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; TIME FACTORS;

EID: 33947387817     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060178     Document Type: Article

References (47)

1. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000, 52:639-672
2. Okada H, Watanabe Y, Inoue T, Kobayashi T, Kikuta T, Kanno Y, Ban S, Suzuki H: Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor. Biochem Biophys Res Commun 2004, 314:403-408
3. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999, 103:627-635
4. Suzuki Y, Lopez-Franco O, Gomez-Garre D, Tejera N, Gomez-Guerrero C, Sugaya T, Bernal R, Blanco J, Ortega L, Egido J: Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice. Am J Pathol 2001, 159:1895-1904
5. Lafayette R, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992, 90:766-771
6. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, Makino H: Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2001, 12:317-325
7. Allen TJ, Cao Z, Youssef S, Hulthen UL, Cooper ME: Role of angiotensin II and bradykinin in experimental diabetic nephropathy: functional and structural studies. Diabetes 1997, 46:1612-1618
8. Yu CM, Tipoe GL, Wing-Hon Lai K, Lau CP: Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 2001, 38:1207-1215
9. Wu L, Iwai M, Nakagami H, Li Z, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M: Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001, 104:2716-2721
10. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H: Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001, 34:745-750
11. Stoll M, Unger T: Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept 2001, 99:175-182
12. Lehtonen JY, Daviet L, Nahmias C, Horiuchi M, Dzau VJ: Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol Endocrinol 2004, 13:1051-1060
13. Moore SA, Huang N, Hinthong O, Andres RD, Grammatopoulos TN, Weyhenmeyer JA: Human angiotensin II type-2 receptor inhibition of insulin-mediated ERK-2 activity via a G-protein coupled signaling pathway. Mol Brain Res 2004, 124:62-69
14. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, Gao W, Scholey J: Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol 2005, 16:1266-1278
15. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I: Accelerated fibrosis and collagen deposition develop in the real interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998, 53:937-944
16. Morrissey JJ, Klahr S: Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 1999, 276:F39-F45
17. Hashimoto N, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H: Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol 2004, 286:F516-F525
18. Esteban V, Lorenzo O, Ruperez M, Suzuki Y, Mezzano S, Blanco J, Kretzler M, Sugaya T, Egido J, Ruiz-Ortega M: Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004, 15:1514-1529
19. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, de Gasparo M, Cooper ME: Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 2002, 13:1773-1787
20. Tejera N, Gomez-Garre D, Lazaro A, Gallego-Delgado J, Alonso C, Blanco J, Ortiz A, Egido J: Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol 2004, 164:1817-1826
21. Santibanez JF, Guerrero J, Quintanilla M, Fabra A, Martinez J: Transforming growth factor-β1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 2002, 296:267-273
22. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, Suzuki H: Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005, 16:133-143
23. Okada H, Moriwaki K, Kalluri R, Imai H, Ban S, Takahama M, Suzuki H: Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Good-pasture syndrome. Kidney Int 2000, 57:927-936
24. Akishita M, Iwai M, Wu L, Zhang L, Ouchi Y, Dzau VJ, Horiuchi M: Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 2000, 102:1684-1689
25. Takaya K, Koya D, Isono M, Sugimoto T, Sugaya T, Kashiwagi A, Haneda M: Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol 2003, 284:F1037-F1045
26. Mifune M, Sasamura H, Shimizu-Hirota R, Miyazaki H, Saruta T: Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 2000, 36:845-850
27. Okada H, Watanabe Y, Kikuta T, Kobayashi T, Kanno Y, Sugaya T, Suzuki H: Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol 2004, 15:2402-2413
28. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Kopp JB, Carey RM, Suzuki H: Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol 2002, 160:765-772
29. von Harsdorf R, Edwards JG, Shen YT, Kudej RK, Dietz R, Leinwand LA, Nadal-Ginard B, Vatner SF: Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J Clin Invest 1997, 100:1294-1304
30. Kim JH, Ha IS, Hwang CI, Lee YJ, Kim J, Yang SH, Kim YS, Cao YA, Choi S, Park WY: Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-κB in immune complex kidney disease. Kidney Int 2004, 66:1826-1837
31. Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ: Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997, 100:582-588
32. Bokemeyer D, Panek D, Kramer HJ, Lindemann M, Kitahara M, Boor P, Kerjaschki D, Trzaskos JM, Floege J, Ostendorf T: In vivo identification of the mitogen-activated protein kinase cascade as a central pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2002, 13:1473-1480
33. Masaki T, Stambe C, Hill PA, Dowling J, Atkins RC, Nikolic-Paterson DJ: Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol 2004, 15:1835-1843
34. Stambe C, Atkins RC, Tesch GH, Kapoun AM, Hill PA, Schreiner GF, Nikolic-Paterson DJ: Blockade of p38a MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 2003, 14:338-351
35. Ruiz-Ortega M, Esteban V, Suzuki Y, Ruperez M, Mezzano S, Ardiles L, Justo P, Ortiz A, Egido J: Renal expression of angiotensin type 2 receptors during kidney damage. Kidney Int 2003, 64(Suppl 86):S21-S26
36. Tian W, Zhang Z, Cohen DM: MAPK signaling and the kidney. Am J Physiol 2000, 279:F593-F604
37. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, Homer RJ, Zhu Z, Rincon M, Mossman BT, Elias JA: ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 2006, 116:163-173
38. Shibasaki Y, Matsubara H, Nozawa Y, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T: Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase. Hypertension 2001, 38:367-372
39. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA: Temporal control of NF-κB activation by ERK differentially regulates interleukin-1β- induced gene expression. J Biol Chem 2004, 279:1323-1329
40. Moon SK, Cha BY, Kim CH: ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 2004, 198:417-427
41. Okada H, Watanabe Y, Kobayashi T, Kikuta T, Kanno Y, Suzuki H: Angiotensin II type 1 and type 2 receptors reciprocally modulate pro-inflammatory/pro-fibrotic reactions in activated splenic lymphocytes. Am J Nephrol 2004, 24:322-329
42. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. J Clin Invest 1997, 100:1047-1058
43. Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J: Systemic infusion of angiotensin II into normal rats activates nuclear factor-κB and AP-1 in the kidney. Am J Pathol 2001, 158:1743-1756
44. Esteban V, Ruperez M, Vita JR, Lopez ES, Mezzano S, Plaza JJ, Egido J, Ruiz-Ortega M: Effects of simultaneous blockade of AT1 and AT2 receptors on the NFκB pathway and renal inflammatory response. Kidney Int 2003, 64(Suppl 86):S33-S38
45. Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney A, Inagami T: Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001, 104:346-351
46. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002, 39:316-322
47. Ruiz-Ortega M, Lorenzo O, Ruperez M, Koenig S, Wittig B, Egido J: Angiotensin II activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells. Circ Res 2000, 86:1266-1272